Literature DB >> 18039187

N-terminal pro-brain natriuretic peptide (NT-proBNP) serum concentrations in apparently healthy Bosnian women.

Almira Hadzović-Dzuvo1, Elma Kucukalić-Selimović, Emina Nakas-Ićindić, Asija Zaćiragić, Zdenka Drazeta.   

Abstract

Brain natriuretic peptide (BNP) is a cardiac hormone secreted predominantly from the ventricles. This hormone is produced as pre-prohormone BNP (pro BNP), than cleaved by corine to biologically active 32-aminoacid BNP and non-biologically active N-terminal-pro brain natriuretic peptide (NTproBNP). NTproBNP has been found to be a useful marker for the diagnosis of heart failure and left ventricular systolic dysfunction. Recent studies showed that concentration of BNP and NTproBNP predict cardiovascular disease in apparently healthy individuals but their full screening characteristics are not firmly established. As NTproBNP serum concentration is altered by numerous factors there are also interindividual variations in NTproBNP values. There are no previous results for Bosnian population so the aim of this study was to asses normal range of NTproBNP serum concentrations in apparently healthy women using electrochemiluminescence immunoassay (Elecsys, Roche Diagnostic). A group of 45, healthy females, aged 39.19 (+/-6.62), were enrolled in this study. Mean serum concentration of NTproBNP was 60.32 (+/-36.25) pg/ml, with the range of 112,60 pg/ml (minimum-maximum: 13.6-126.00 pg/ml). We conclude that NTproBNP serum concentration in apparently healthy Bosnian women was not different from the average values of NTproBNP obtained on Europen's population. Thus, we suggest that the NTproBNP serum upper cut off values measured by using electrochemiluminescence immunoassay "ECLIA" (Elecsys 2010, Roche Diagnostic) for Bosnian females, aged < or =50 years, should be 155 pg/ml as reported by Roche Diagnostic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039187      PMCID: PMC5728602          DOI: 10.17305/bjbms.2007.3018

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  11 in total

1.  Screening for cardiovascular disease using B-type natriuretic peptides: detecting an imbalance of the four humours.

Authors:  David W Markham; James A de Lemos
Journal:  Eur Heart J       Date:  2005-08-25       Impact factor: 29.983

2.  Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors.

Authors:  Georg Hess; Stefan Runkel; Dietmar Zdunek; Walter E Hitzler
Journal:  Clin Chim Acta       Date:  2005-10       Impact factor: 3.786

3.  What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?

Authors:  Gavin I W Galasko; Avijit Lahiri; Sophie C Barnes; Paul Collinson; Roxy Senior
Journal:  Eur Heart J       Date:  2005-07-21       Impact factor: 29.983

4.  N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.

Authors:  Georg Hess; Stefan Runkel; Dietmar Zdunek; Walter E Hitzler
Journal:  Clin Lab       Date:  2005       Impact factor: 1.138

5.  N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Authors:  Caroline Kistorp; Ilan Raymond; Frants Pedersen; Finn Gustafsson; Jens Faber; Per Hildebrandt
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

6.  N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.

Authors:  Xiaomin Shi; Guobing Xu; Tiean Xia; Yixin Song; Qing Lin
Journal:  Clin Chim Acta       Date:  2005-10       Impact factor: 3.786

Review 7.  The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.

Authors:  J Mair; A Hammerer-Lercher; B Puschendorf
Journal:  Clin Chem Lab Med       Date:  2001-07       Impact factor: 3.694

8.  The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Authors:  I Raymond; B A Groenning; P R Hildebrandt; J C Nilsson; M Baumann; J Trawinski; F Pedersen
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

9.  N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure.

Authors:  R S Gardner; F Ozalp; A J Murday; S D Robb; T A McDonagh
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

Review 10.  Essential biochemistry and physiology of (NT-pro)BNP.

Authors:  Christian Hall
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.